Tag: vedolizumab

Takeda’s Entyvio bests AbbVie’s Humira in ulcerative colitis trial

by Selina McKee | Mar 11, 2019 | News | 0

Takeda’s Entyvio has beaten AbbVie’s Humira on achieving clinical remission in patients with ulcerative colitis, in the first trial to directly compare the efficacy and safety of two commonly used biologics for the disease.

Sub-cutaneous form of Entyvio hits PhIII safety, efficacy goals

by Selina McKee | Jul 19, 2018 | News | 0

Takeda says it has late-stage trial results showing the benefit of an investigational subcutaneous formulation of Entyvio to patients with ulcerative colitis.